Viracta Therapeutics Cash from Financing (TTM) Insights

Viracta Therapeutics Inc (VIRX)

0.8102 -0.03 (-3.55%) USD | NASDAQ | May 03, 16:00

0.822 +0.01 (+1.46%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	0.438M
September 30, 2023	21.63M
June 30, 2023	22.73M
March 31, 2023	22.55M
December 31, 2022	22.54M
September 30, 2022	0.936M
June 30, 2022	-0.079M

Date	Value
March 31, 2022	0.035M
December 31, 2021	62.42M
September 30, 2021	102.35M
June 30, 2021	107.25M
March 31, 2021	107.38M
December 31, 2020	44.98M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.079M

Minimum

Jun 2022

107.38M

Maximum

Mar 2021

39.63M

Average

22.55M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks